SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) play critical roles in cancer development.
• The specific functions of lncRNAs in human lung adenocarcinoma (LUAD) are not fully understood.
• Small nucleolar RNA host gene 6 (SNHG6) is a novel lncRNA implicated in various cancers.

Purpose of the Study:

• To investigate the role and mechanism of SNHG6 in human lung adenocarcinoma (LUAD).
• To explore the potential of SNHG6 as a therapeutic target in LUAD.

Main Methods:

• Analysis of SNHG6 expression in LUAD tissues and correlation with clinical parameters.
• In vitro gain- and loss-of-function experiments to assess SNHG6's impact on LUAD cell behavior.
• In vivo xenograft experiments to evaluate SNHG6's role in tumor formation.
• Mechanistic studies to elucidate the molecular pathway involving SNHG6, miR-26a-5p, and E2F7.

Main Results:

• SNHG6 was significantly upregulated in LUAD tissues and associated with advanced TNM stage, larger tumor size, and poorer overall survival.
• SNHG6 overexpression promoted cell cycle progression, proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in vitro.
• SNHG6 knockdown inhibited xenograft tumor formation in vivo.
• SNHG6 acted as a competing endogenous RNA (ceRNA) by sponging miR-26a-5p, thereby regulating E2F7 expression, cell motility, and EMT.

Conclusions:

• SNHG6 functions as an oncogenic lncRNA in LUAD.
• SNHG6 promotes LUAD progression through the miR-26a-5p/E2F7 axis.
• SNHG6 represents a potential therapeutic target for LUAD treatment.